The DOI matches its Crossref record.
Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
Open accessAbstract
We studied the origin of the neutrophil-activating peptide NAP-2, a presumed 70 amino acid cleavage product of platelet basic protein (PBP) and connective tissue-activating peptide III (CTAP-III). Purified human blood monocytes or lymphocytes were cultured with or without stimuli (LPS or PHA) in the presence or absence of platelet-release supernatant, and the formation of NAP-2 and other neutrophil-activating peptides was monitored. NAP-2 was generated whenever monocytes and platelet release supernatant were present. When a monocyte stimulus was added, NAF/NAP-1 was also formed, and in the presence of LPS a third, less potent neutrophil-stimulating fraction, consisting of NAP-2 variants with 73, 74, and 75 residues, also appeared. Monocytes alone did not yield NAP-2 and no neutrophil-activating peptide was generated by lymphocytes. The monocyte-conditioned medium was found to cleave purified CTAP-III into NAP-2 through proteinases that were highly sensitive to PMSF, moderately sensitive to leupeptin and insensitive to EDTA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Self-citationlnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Self-citationInterleukin‐8, a chemotactic and inflammatory cytokine
Baggiolini, M., & Clark-Lewis, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80909-z · Cited by 989
Self-citationCXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Emerging roles for platelets as immune and inflammatory cells
Morrell, C. N., Aggrey, A. A., Chapman, L. M., & Modjeski, K. L. (2014) · Blood · doi:10.1182/blood-2013-11-462432 · Cited by 735
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Kameyoshi, Y., Dörschner, A., Mallet, A. I., Christophers, E., & Schröder, J. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.587 · Cited by 670
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1
McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107736200 · Cited by 655
The role of CXC chemokines and their receptors in cancer
Vandercappellen, J., Van Damme, J., & Struyf, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.050 · Cited by 643
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
MOREL, F., DOUSSIERE, J., & VIGNAIS, P. V. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16312.x · Cited by 565
CC chemokines in allergic inflammation
Baggiolini, M., & Dahinden, C. A. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90156-2 · Cited by 529
Self-citationTwo Distinct Cytokines Released from a Human Aminoacyl-tRNA Synthetase
Wakasugi, K., & Schimmel, P. (1999) · Science · doi:10.1126/science.284.5411.147 · Cited by 504
Hébert, C. A., Vitangcol, R. V., & Baker, J. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55160-7 · Cited by 369
Walz, A., Burgener, R., Car, B., Baggiolini, M., Kunkel, S. L., & Strieter, R. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1355 · Cited by 353
Self-citationPotential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Cheng, Y., Ma, X.-L., Wei, Y.-Q., & Wei, X.-W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.005 · Cited by 344
Krijgsveld, J., Zaat, S. A. J., Meeldijk, J., van Veelen, P. A., Fang, G., Poolman, B., Brandt, E., Ehlert, J. E., Kuijpers, A. J., Engbers, G. H. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.27.20374 · Cited by 338
Structure-function relationships of antimicrobial peptides
Hwang, P. M., & Vogel, H. J. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-2-3-235 · Cited by 313
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets
Clemetson, K. J., Clemetson, J. M., Proudfoot, A. E. I., Power, C. A., Baggiolini, M., & Wells, T. N. C. (2000) · Blood · doi:10.1182/blood.v96.13.4046 · Cited by 271
Self-citationChemokine and inflammatory cytokine changes during chronic wound healing
Fivenson, D. P., Faria, D. T., Nickoloff, B. J., Poverini, P. J., Kunkel, S., Burdick, M., & Strieter, R. M. (1997) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1997.50405.x · Cited by 118
Chemokine-protease interactions in cancer
Van Damme, J., Struyf, S., & Opdenakker, G. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.007 · Cited by 71
Metadata
- Authors
- Walz, A., & Baggiolini, M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1990-02-01
- Volume
- 171
- Issue
- 2
- Pages
- 449-454
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2155503448
- Cited by
- 163
- References
- 0
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.